selumetinib (AZD6244)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for selumetinib (AZD6244), covering 2018-06-20 to 2018-06-20. Get the full timeline:
Most recent: Clinical Trial Update: AZD6244 in Combination With Docetaxel Versus Docetaxel Alone in KRAS Mutation Positive NSCLC Patients [Phase 2]